Atovaquone-Proguanil SPE2D224D0005
Summary
AI-generated · Mar 09, 2026Two one-year option periods are being exercised on an existing Atovaquone-Proguanil national contract, extending the supply arrangement (modifications P00001 and P00003 correspond to Option Year 1 and Option Year 2, respectively).
A related modification (P00002) is adjusted in accordance with DoD Class Deviation 2025-O0003. The contract was awarded to Golden State Medical Supply, Inc. for roughly $20.5 million.
Modification SPE2D224D0005 P00003 to exercise Option Year 2 effective April 4, 2026 through April 3, 2027. Modification SPE2D224D0005 P00002 is modified in accordance with DoD Class Deviation 2025-O0003. Modification SPE2D224D0005 P00001 to exercise Option Year 1 effective April 4, 2025 through April 3, 2026. Atovaquone National Contract SPE2D2-24-D-0005
From Award Notice posted on Mar 04, 2026Notice history
1Details
Award Information
Award Notices
Posted: Mar 04, 2026
Modification SPE2D224D0005 P00003 to exercise Option Year 2 effective April 4, 2026 through April 3, 2027. Modification SPE2D224D0005 P00002 is modified in accordance with DoD Class Deviation 2025-O0003. Modification SPE2D224D0005 P00001 to exercise Option Year 1 effective April 4, 2025 through Apri...
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| GOLDEN STATE MEDICAL SUPPLY, INC. | GQLDJJ8AQNN5 | 1HT23 | Camarillo, CA |
Contacts
Phone
Phone
Agency
Place of Performance
IND